BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7104262)

  • 1. Tranexamic acid, intrauterine contraceptive devices and fatal cerebral arterial thrombosis. Case report.
    Agnelli G; Gresele P; De Cunto M; Gallai V; Nenci GG
    Br J Obstet Gynaecol; 1982 Aug; 89(8):681-2. PubMed ID: 7104262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated angiitis of the brain in a young female on the contraceptive pill.
    Nagaratnam N; James WE
    Postgrad Med J; 1987 Dec; 63(746):1085-6. PubMed ID: 3451235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Budd-Chiari Syndrome and antithrombin III deficiency.
    McClure S; Dincsoy HP; Glueck H
    Am J Clin Pathol; 1982 Aug; 78(2):236-41. PubMed ID: 7102823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognizing malignancy in intrauterine contraceptive device users.
    Castadot MJ; Robinowitz M; Chervenak FA; Sedlis A; Boria MC
    Am J Obstet Gynecol; 1980 Apr; 136(7):966-7. PubMed ID: 7361845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical migration of intrauterine device.
    Dietrick DD; Issa MM; Kabalin JN; Bassett JB
    J Urol; 1992 Jan; 147(1):132-4. PubMed ID: 1729505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between antifibrinolytic and antiprostaglandin treatment in the reduction of increased menstrual blood loss in women with intrauterine contraceptive devices.
    Ylikorkala O; Viinikka L
    Br J Obstet Gynaecol; 1983 Jan; 90(1):78-83. PubMed ID: 6336951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrauterine contraceptive devices. Complications associated with their use.
    Nagel TC
    Postgrad Med; 1983 Mar; 73(3):155-64. PubMed ID: 6828391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications associated with the unsuspected presence of intrauterine contraceptive devices.
    Porges RF
    Am J Obstet Gynecol; 1973 Jun; 116(4):579-80. PubMed ID: 4709493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tranexamic acid and arterial thrombosis.
    Davies D; Howell DA
    Lancet; 1977 Jan; 1(8001):49. PubMed ID: 63691
    [No Abstract]   [Full Text] [Related]  

  • 11. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant).
    Clark DA; Wang S; Rogers P; Vince G; Affandi B
    Hum Reprod; 1996 Jul; 11(7):1438-44. PubMed ID: 8671483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Local proteinase inhibitor concentration in uterine secretions with intrauterine spirals (IUD) in situ (proceedings)].
    Tauber PF; Herting W; Kurz E; Feichter GE
    Arch Gynakol; 1977 Jul; 224(1-4):32-3. PubMed ID: 579835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical application of inhibitors of fibrinolysis.
    Verstraete M
    Drugs; 1985 Mar; 29(3):236-61. PubMed ID: 2580684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of intrauterine contraceptive devices on the ultrastructure of the endometrium in relation to bleeding complications.
    Sheppard BL; Bonnar J
    Am J Obstet Gynecol; 1983 Aug; 146(7):829-39. PubMed ID: 6869454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting intrauterine contraceptive device performance. I. Endometrial cavity length.
    Hasson HM; Berger GS; Edelman DA
    Am J Obstet Gynecol; 1976 Dec; 126(8):973-81. PubMed ID: 998687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double (uterine and ectopic) pregnancy of a patient using an intrauterine contraceptive device.
    Sisa CM
    Am J Obstet Gynecol; 1984 Aug; 149(8):912. PubMed ID: 6465263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staphylococcal septicaemia after insertion of an intrauterine contraceptive device.
    Geddes AM
    Br Med J; 1980 Dec; 281(6255):1639. PubMed ID: 7448549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptives and postoperative venous thrombosis.
    DeStefano F; Peterson HB; Ory HW; Layde PM
    Am J Obstet Gynecol; 1982 May; 143(2):227-8. PubMed ID: 7081337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.